+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Artificial Intelligence in Diagnostics Market Size, Share & Trends Analysis Report by Component, Diagnosis Type, Region, and Segment Forecasts, 2026-2033- Product Image
Artificial Intelligence in Diagnostics Market Size, Share & Trends Analysis Report by Component, Diagnosis Type, Region, and Segment Forecasts, 2026-2033- Product Image
New

Artificial Intelligence in Diagnostics Market Size, Share & Trends Analysis Report by Component, Diagnosis Type, Region, and Segment Forecasts, 2026-2033

  • PDF Icon

    Report

  • 150 Pages
  • January 2026
  • Region: Global
  • Grand View Research
  • ID: 5415444
REQUEST CUSTOMIZATION
Description Jump to:
The global artificial intelligence in diagnostics market size was estimated at USD 1.97 billion in 2025 and is projected to reach USD 9.68 billion by 2033, growing at a CAGR of 21.74% from 2026 to 2033. Market growth is driven by advancements in machine learning and deep learning, enabling faster, more accurate diagnostic solutions.

In oncology, cardiology, and neurology, among the areas, the growing demand for early disease detection has led to increased adoption of AI technologies. For instance, in February 2024, Royal Philips introduced the Philips CT 5300, an advanced AI-powered CT system designed for diagnostics, interventional procedures, and screenings. The adaptable X-ray CT system enhances diagnostic accuracy, streamlines workflows, and optimizes system availability.

Rising prevalence of chronic diseases such as diabetes, cancer, cardiovascular disorders, etc., coupled with the increasing demand for early & accurate diagnosis, are significant factors driving market growth. The increasing incidence of cancer globally has led to a growing dependence on AI in the field of oncology. According to the NIH estimates of 2023, approximately 2.0 million individuals in the U.S. are diagnosed with cancer. Breast cancer was the most diagnosed cancer, with an estimated 297,790 cases in women and 2,800 cases in men. Similarly, according to the Centers for Disease Control and Prevention (CDC), 919,032 people died from cardiovascular disease in the U.S. in 2023, equivalent to one in every three deaths.

Such a high prevalence increases the diagnostic workload. Advancements in healthcare IT infrastructure and ongoing technological developments in cloud storage, computing, and machine learning algorithms support the integration of AI-powered systems into diagnostics to provide efficient & accurate diagnoses, allowing care providers to devise timely & appropriate treatment plans. Pathology and radiology services are witnessing a widespread adoption of AI-based algorithms. For instance, in January 2026, Alpenglow Biosciences and PathNet formed a strategic partnership to develop and commercialize 3D AI diagnostic tests for prostate and bladder cancer. The collaboration advances urologic oncology from 2D to 3D pathology in the U.S., integrating imaging, AI analytics, and workflows for enhanced accuracy.

“PathNet’s leadership in urologic oncology, digitization, AI, and strong national footprint make them an exceptional partner as we bring clinical 3D pathology to market. Together, we are building diagnostic tools that deliver insights not achievable with conventional 2D histology.”
  • Dr. Nicholas Reder, CEO of Alpenglow Biosciences

In addition, several AI-powered tools are used to diagnose chronic kidney disease (CKD) & kidney function tests, and various chronic diseases. For instance, in May 2024, Premier, Inc. partnered with AstraZeneca to launch the Uncover CKD - Care Collective initiative. The aim is to identify patients with undiagnosed CKD, raise awareness among healthcare providers, and assist U.S. health systems in improving their CKD diagnosis, treatment, and management. Leveraging Premier’s PINC AI technology and services platform, the initiative seeks to address the increasing prevalence of undiagnosed CKD and its associated economic burden on the U.S. healthcare system.

Global Artificial Intelligence In Diagnostics Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends across sub-segments from 2021 to 2033. For this study, the analyst has segmented the global artificial intelligence in diagnostics market report based on component, diagnosis type, and region:

Component Outlook (Revenue, USD Million, 2021-2033)

  • Software
  • Hardware
  • Services

Diagnosis Type Outlook (Revenue, USD Million, 2021-2033)

  • Cardiology
  • Oncology
  • Pathology
  • Radiology
  • Chest and Lung
  • Neurology
  • Others

Regional Outlook (Revenue, USD Million, 2021-2033)

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa (MEA)

Why You Should Buy This Report

  • Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listings for you to stay ahead of the curve

This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Component
1.1.2. Diagnosis type
1.1.3. Regional scope
1.1.4. Estimates and forecast timeline.
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database.
1.3.2. internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Component outlook
2.2.2. Diagnosis type outlook
2.3. Regional outlook
2.4. Competitive Insights
Chapter 3. Artificial Intelligence In Diagnostics Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.2. Market restraint analysis
3.2.3. Market opportunity analysis
3.2.4. Market challenges analysis
3.3. Artificial Intelligence In Diagnostics Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Economic landscape
3.3.2.3. Social landscape
3.3.2.4. Technological landscape
3.3.2.5. Environmental landscape
3.3.2.6. Legal landscape
3.4. Case Study Insights
Chapter 4. Artificial Intelligence In Diagnostics Market: Component Estimates & Trend Analysis
4.1. Component Market Share, 2025 & 2033
4.2. Segment Dashboard
4.3. Global Artificial Intelligence In Diagnostics Market, By Component Outlook
4.4. Software
4.4.1. Market estimates and forecast, 2021 to 2033 (USD Million)
4.5. Hardware
4.5.1. Market estimates and forecast, 2021 to 2033 (USD Million)
4.6. Services
4.6.1. Market estimates and forecast, 2021 to 2033 (USD Million)
Chapter 5. Artificial Intelligence In Diagnostics Market: Diagnosis Type Estimates & Trend Analysis
5.1. Diagnosis Type Market Share, 2025 & 2033
5.2. Segment Dashboard
5.3. Global Artificial Intelligence In Diagnostics Market, By Diagnosis Type Outlook
5.4. Cardiology
5.4.1. Market estimates and forecast, 2021 to 2033 (USD Million)
5.5. Oncology
5.5.1. Market estimates and forecast, 2021 to 2033 (USD Million)
5.6. Pathology
5.6.1. Market estimates and forecast, 2021 to 2033 (USD Million)
5.7. Radiology
5.7.1. Market estimates and forecast, 2021 to 2033 (USD Million)
5.8. Chest and Lung
5.8.1. Market estimates and forecast, 2021 to 2033 (USD Million)
5.9. Neurology
5.9.1. Market estimates and forecast, 2021 to 2033 (USD Million)
5.10. Others
5.10.1. Market estimates and forecast, 2021 to 2033 (USD Million)
Chapter 6. Artificial Intelligence In Diagnostics Market: Regional Estimates & Trend Analysis, By Component, By Diagnosis Type
6.1. Regional Market Share Analysis, 2025 & 2033
6.2. Regional Market Dashboard
6.3. Global Regional Market Snapshot
6.4. Market Size, & Forecasts Trend Analysis, 2021 to 2033:
6.5. North America
6.5.1. U.S.
6.5.1.1. Key country dynamics
6.5.1.2. Regulatory framework
6.5.1.3. Competitive scenario
6.5.1.4. U.S. market estimates and forecasts, 2021 to 2033 (USD Million)
6.5.2. Canada
6.5.2.1. Key country dynamics
6.5.2.2. Regulatory framework
6.5.2.3. Competitive scenario
6.5.2.4. Canada market estimates and forecasts, 2021 to 2033 (USD Million)
6.5.3. Mexico
6.5.3.1. Key country dynamics
6.5.3.2. Regulatory framework
6.5.3.3. Competitive scenario
6.5.3.4. Mexico market estimates and forecasts, 2021 to 2033 (USD Million)
6.6. Europe
6.6.1. UK
6.6.1.1. Key country dynamics
6.6.1.2. Regulatory framework
6.6.1.3. Competitive scenario
6.6.1.4. UK market estimates and forecasts, 2021 to 2033 (USD Million)
6.6.2. Germany
6.6.2.1. Key country dynamics
6.6.2.2. Regulatory framework
6.6.2.3. Competitive scenario
6.6.2.4. Germany market estimates and forecasts, 2021 to 2033 (USD Million)
6.6.3. France
6.6.3.1. Key country dynamics
6.6.3.2. Regulatory framework
6.6.3.3. Competitive scenario
6.6.3.4. France market estimates and forecasts, 2021 to 2033 (USD Million)
6.6.4. Italy
6.6.4.1. Key country dynamics
6.6.4.2. Regulatory framework
6.6.4.3. Competitive scenario
6.6.4.4. Italy market estimates and forecasts, 2021 to 2033 (USD Million)
6.6.5. Spain
6.6.5.1. Key country dynamics
6.6.5.2. Regulatory framework
6.6.5.3. Competitive scenario
6.6.5.4. Spain market estimates and forecasts, 2021 to 2033 (USD Million)
6.6.6. Norway
6.6.6.1. Key country dynamics
6.6.6.2. Regulatory framework
6.6.6.3. Competitive scenario
6.6.6.4. Norway market estimates and forecasts, 2021 to 2033 (USD Million)
6.6.7. Sweden
6.6.7.1. Key country dynamics
6.6.7.2. Regulatory framework
6.6.7.3. Competitive scenario
6.6.7.4. Sweden market estimates and forecasts, 2021 to 2033 (USD Million)
6.6.8. Denmark
6.6.8.1. Key country dynamics
6.6.8.2. Regulatory framework
6.6.8.3. Competitive scenario
6.6.8.4. Denmark market estimates and forecasts, 2021 to 2033 (USD Million)
6.7. Asia Pacific
6.7.1. Japan
6.7.1.1. Key country dynamics
6.7.1.2. Regulatory framework
6.7.1.3. Competitive scenario
6.7.1.4. Japan market estimates and forecasts, 2021 to 2033 (USD Million)
6.7.2. China
6.7.2.1. Key country dynamics
6.7.2.2. Regulatory framework
6.7.2.3. Competitive scenario
6.7.2.4. China market estimates and forecasts, 2021 to 2033 (USD Million)
6.7.3. India
6.7.3.1. Key country dynamics
6.7.3.2. Regulatory framework
6.7.3.3. Competitive scenario
6.7.3.4. India market estimates and forecasts, 2021 to 2033 (USD Million)
6.7.4. Australia
6.7.4.1. Key country dynamics
6.7.4.2. Regulatory framework
6.7.4.3. Competitive scenario
6.7.4.4. Australia market estimates and forecasts, 2021 to 2033 (USD Million)
6.7.5. South Korea
6.7.5.1. Key country dynamics
6.7.5.2. Regulatory framework
6.7.5.3. Competitive scenario
6.7.5.4. South Korea market estimates and forecasts, 2021 to 2033 (USD Million)
6.7.6. Thailand
6.7.6.1. Key country dynamics
6.7.6.2. Regulatory framework
6.7.6.3. Competitive scenario
6.7.6.4. Singapore market estimates and forecasts, 2021 to 2033 (USD Million)
6.8. Latin America
6.8.1. Brazil
6.8.1.1. Key country dynamics
6.8.1.2. Regulatory framework
6.8.1.3. Competitive scenario
6.8.1.4. Brazil market estimates and forecasts, 2021 to 2033 (USD Million)
6.8.2. Argentina
6.8.2.1. Key country dynamics
6.8.2.2. Regulatory framework
6.8.2.3. Competitive scenario
6.8.2.4. Argentina market estimates and forecasts, 2021 to 2033 (USD Million)
6.9. MEA
6.9.1. South Africa
6.9.1.1. Key country dynamics
6.9.1.2. Regulatory framework
6.9.1.3. Competitive scenario
6.9.1.4. South Africa market estimates and forecasts, 2021 to 2033 (USD Million)
6.9.2. Saudi Arabia
6.9.2.1. Key country dynamics
6.9.2.2. Regulatory framework
6.9.2.3. Competitive scenario
6.9.2.4. Saudi Arabia market estimates and forecasts, 2021 to 2033 (USD Million)
6.9.3. UAE
6.9.3.1. Key country dynamics
6.9.3.2. Regulatory framework
6.9.3.3. Competitive scenario
6.9.3.4. UAE market estimates and forecasts, 2021 to 2033 (USD Million)
6.9.4. Kuwait
6.9.4.1. Key country dynamics
6.9.4.2. Regulatory framework
6.9.4.3. Competitive scenario
6.9.4.4. Kuwait market estimates and forecasts, 2021 to 2033 (USD Million)
Chapter 7. Competitive Landscape
7.1. Competitor Growth Readiness Index (GRI), 2025
7.2. Competitor Capability Matrix, 2025
7.3. Company Categorization
7.4. Company Market Position Analysis
7.5. Strategy Mapping
7.6. Company Profiles/Listing
7.6.1. Key company market share analysis, 2025
7.6.2. Siemens Healthineers
7.6.2.1. Company overview
7.6.2.2. Financial performance
7.6.2.3. Product benchmarking
7.6.2.4. Strategic initiatives
7.6.3. Zebra Technologies Corp.
7.6.3.1. Company overview
7.6.3.2. Financial performance
7.6.3.3. Product benchmarking
7.6.3.4. Strategic initiatives
7.6.4. Riverain Technologies
7.6.4.1. Company overview
7.6.4.2. Financial performance
7.6.4.3. Product benchmarking
7.6.4.4. Strategic initiatives
7.6.5. Vuno, Inc.
7.6.5.1. Company overview
7.6.5.2. Financial performance
7.6.5.3. Product benchmarking
7.6.5.4. Strategic initiatives
7.6.6. Aidoc
7.6.6.1. Company overview
7.6.6.2. Financial performance
7.6.6.3. Product benchmarking
7.6.6.4. Strategic initiatives
7.6.7. NovaSignal Corporation (previously known as Neural Analytics, acquired by NeuraSignal, Inc.)
7.6.7.1. Company overview
7.6.7.2. Financial performance
7.6.7.3. Product benchmarking
7.6.7.4. Strategic initiatives
7.6.8. Koninklijke Philips N.V.
7.6.8.1. Company overview
7.6.8.2. Financial performance
7.6.8.3. Product benchmarking
7.6.8.4. Strategic initiatives
7.6.9. Digital Diagnostics, Inc.
7.6.9.1. Company overview
7.6.9.2. Financial performance
7.6.9.3. Product benchmarking
7.6.9.4. Strategic initiatives
7.6.10. GE Healthcare
7.6.10.1. Company overview
7.6.10.2. Financial performance
7.6.10.3. Product benchmarking
7.6.10.4. Strategic initiatives
7.6.11. AliveCor Inc.
7.6.11.1. Company overview
7.6.11.2. Financial performance
7.6.11.3. Product benchmarking
7.6.11.4. Strategic initiatives
7.6.12. F. Hoffmann-La Roche Ltd
7.6.12.1. Company overview
7.6.12.2. Financial performance
7.6.12.3. Product benchmarking
7.6.12.4. Strategic initiatives
List of Tables
Table 1. List of secondary sources
Table 2. List of abbreviations
Table 3. Global AI in diagnostics market, by component, 2021-2033 (USD Million)
Table 4. Global AI in diagnostics market, by diagnosis type, 2021-2033 (USD Million)
Table 5. North America AI in diagnostics market, by country, 2021-2033 (USD Million)
Table 6. North America AI in diagnostics market, by component, 2021-2033 (USD Million)
Table 7. North America AI in diagnostics market, by diagnosis type, 2021-2033 (USD Million)
Table 8. U.S. AI in diagnostics market, by component, 2021-2033 (USD Million)
Table 9. U.S. AI in diagnostics market, by diagnosis type, 2021-2033 (USD Million)
Table 10. Canada AI in diagnostics market, by component, 2021-2033 (USD Million)
Table 11. Canada AI in diagnostics market, by diagnosis type, 2021-2033 (USD Million)
Table 12. Mexico AI in diagnostics market, by component, 2021-2033 (USD Million)
Table 13. Mexico AI in diagnostics market, by diagnosis type, 2021-2033 (USD Million)
Table 14. Europe AI in diagnostics market, by country, 2021-2033 (USD Million)
Table 15. Europe AI in diagnostics market, by component, 2021-2033 (USD Million)
Table 16. Europe AI in diagnostics market, by diagnosis type, 2021-2033 (USD Million)
Table 17. UK AI in diagnostics market, by component, 2021-2033 (USD Million)
Table 18. UK AI in diagnostics market, by diagnosis type, 2021-2033 (USD Million)
Table 19. Germany AI in diagnostics market, by component, 2021-2033 (USD Million)
Table 20. Germany AI in diagnostics market, by diagnosis type, 2021-2033 (USD Million)
Table 21. France AI in diagnostics market, by component, 2021-2033 (USD Million)
Table 22. France AI in diagnostics market, by diagnosis type, 2021-2033 (USD Million)
Table 23. Italy AI in diagnostics market, by component, 2021-2033 (USD Million)
Table 24. Italy AI in diagnostics market, by diagnosis type, 2021-2033 (USD Million)
Table 25. Spain AI in diagnostics market, by component, 2021-2033 (USD Million)
Table 26. Spain AI in diagnostics market, by diagnosis type, 2021-2033 (USD Million)
Table 27. Norway AI in diagnostics market, by component, 2021-2033 (USD Million)
Table 28. Norway AI in diagnostics market, by diagnosis type, 2021-2033 (USD Million)
Table 29. Denmark AI in diagnostics market, by component, 2021-2033 (USD Million)
Table 30. Denmark AI in diagnostics market, by diagnosis type, 2021-2033 (USD Million)
Table 31. Sweden AI in diagnostics market, by component, 2021-2033 (USD Million)
Table 32. Sweden AI in diagnostics market, by diagnosis type, 2021-2033 (USD Million)
Table 33. Asia Pacific AI in diagnostics market, by country, 2021-2033 (USD Million)
Table 34. Asia Pacific AI in diagnostics market, by component, 2021-2033 (USD Million)
Table 35. Asia Pacific AI in diagnostics market, by diagnosis type, 2021-2033 (USD Million)
Table 36. Japan AI in diagnostics market, by component, 2021-2033 (USD Million)
Table 37. Japan AI in diagnostics market, by diagnosis type, 2021-2033 (USD Million)
Table 38. China AI in diagnostics market, by component, 2021-2033 (USD Million)
Table 39. China AI in diagnostics market, by diagnosis type, 2021-2033 (USD Million)
Table 40. India AI in diagnostics market, by component, 2021-2033 (USD Million)
Table 41. India AI in diagnostics market, by diagnosis type, 2021-2033 (USD Million)
Table 42. Australia AI in diagnostics market, by component, 2021-2033 (USD Million)
Table 43. Australia AI in diagnostics market, by diagnosis type, 2021-2033 (USD Million)
Table 44. South Korea AI in diagnostics market, by component, 2021-2033 (USD Million)
Table 45. South Korea AI in diagnostics market, by diagnosis type, 2021-2033 (USD Million)
Table 46. Thiland AI in diagnostics market, by component, 2021-2033 (USD Million)
Table 47. Thailand AI in diagnostics market, by diagnosis type, 2021-2033 (USD Million)
Table 48. Latin America AI in diagnostics market, by country, 2021-2033 (USD Million)
Table 49. Latin America AI in diagnostics market, by component, 2021-2033 (USD Million)
Table 50. Latin America AI in diagnostics market, by diagnosis type, 2021-2033 (USD Million)
Table 51. Brazil AI in diagnostics market, by component, 2021-2033 (USD Million)
Table 52. Brazil AI in diagnostics market, by diagnosis type, 2021-2033 (USD Million)
Table 53. Argentina AI in diagnostics market, by component, 2021-2033 (USD Million)
Table 54. Argentina AI in diagnostics market, by diagnosis type, 2021-2033 (USD Million)
Table 55. Middle East & Africa AI in diagnostics market, by country, 2021-2033 (USD Million)
Table 56. Middle East & Africa AI in diagnostics market, by component, 2021-2033 (USD Million)
Table 57. Middle East & Africa AI in diagnostics market, by diagnosis type, 2021-2033 (USD Million)
Table 58. South Africa AI in diagnostics market, by component, 2021-2033 (USD Million)
Table 59. South Africa AI in diagnostics market, by diagnosis type, 2021-2033 (USD Million)
Table 60. Saudi Arabia AI in diagnostics market, by component, 2021-2033 (USD Million)
Table 61. Saudi Arabia AI in diagnostics market, by diagnosis type, 2021-2033 (USD Million)
Table 62. UAE AI in diagnostics market, by component, 2021-2033 (USD Million)
Table 63. UAE AI in diagnostics market, by diagnosis type, 2021-2033 (USD Million)
Table 64. Kuwait AI in diagnostics market, by component, 2021-2033 (USD Million)
Table 65. Kuwait AI in diagnostics market, by diagnosis type, 2021-2033 (USD Million)
List of Figures
Figure 1 Market research process
Figure 2 Information procurement
Figure 3 Primary research pattern
Figure 4 Market research approaches
Figure 5 Value chain-based sizing & forecasting
Figure 6 Market formulation & validation
Figure 7 Market segmentation
Figure 8 Market snapshot
Figure 9 Segment snapshot
Figure 10 Competitive landscape snapshot
Figure 11 Market trends & outlook
Figure 12 PESTLE analysis
Figure 13 Porter’s five forces analysis
Figure 14 AI in diagnostics market: Component outlook and key takeaways
Figure 15 AI in diagnostics market: Component movement analysis
Figure 16 Software market, 2021-2033 (USD Million)
Figure 17 Hardware market, 2021-2033 (USD Million)
Figure 18 Services market, 2021-2033 (USD Million)
Figure 19 AI in diagnostics market: Diagnosis type outlook and key takeaways
Figure 20 AI in diagnostics market: Diagnosis type movement analysis
Figure 21 Cardiology market, 2021-2033 (USD Million)
Figure 22 Oncology market, 2021-2033 (USD Million)
Figure 23 Pathology market, 2021-2033 (USD Million)
Figure 24 Radiology market, 2021-2033 (USD Million)
Figure 25 Chest and lung market, 2021-2033 (USD Million)
Figure 26 Neurology market, 2021-2033 (USD Million)
Figure 27 Others market, 2021-2033 (USD Million)
Figure 28 Regional marketplace: Key takeaways
Figure 29 Regional outlook, 2025 & 2033
Figure 30 AI in diagnostics market: Region movement analysis
Figure 31 North America AI in diagnostics market, 2021-2033 (USD Million)
Figure 32 US AI in diagnostics market, 2021-2033 (USD Million)
Figure 33 Key country dynamics
Figure 34 Canada AI in diagnostics market, 2021-2033 (USD Million)
Figure 35 Key country dynamics
Figure 36 Mexico AI in diagnostics market, 2021-2033 (USD Million)
Figure 37 Key country dynamics
Figure 38 Europe AI in diagnostics market, 2021-2033 (USD Million)
Figure 39 UK AI in diagnostics market, 2021-2033 (USD Million)
Figure 40 Key country dynamics
Figure 41 Germany AI in diagnostics market, 2021-2033 (USD Million)
Figure 42 Key country dynamics
Figure 43 France AI in diagnostics market, 2021-2033 (USD Million)
Figure 44 Key country dynamics
Figure 45 Italy AI in diagnostics market, 2021-2033 (USD Million)
Figure 46 Key country dynamics
Figure 47 Spain AI in diagnostics market, 2021-2033 (USD Million)
Figure 48 Key country dynamics
Figure 49 Norway AI in diagnostics market, 2021-2033 (USD Million)
Figure 50 Key country dynamics
Figure 51 Denmark AI in diagnostics market, 2021-2033 (USD Million)
Figure 52 Key country dynamic
Figure 53 Sweden AI in diagnostics market, 2021-2033 (USD Million)
Figure 54 Key country dynamics
Figure 55 Asia Pacific AI in diagnostics market, 2021-2033 (USD Million)
Figure 56 Japan AI in diagnostics market, 2021-2033 (USD Million)
Figure 57 Key country dynamics
Figure 58 China AI in diagnostics market, 2021-2033 (USD Million)
Figure 59 Key country dynamics
Figure 60 India AI in diagnostics market, 2021-2033 (USD Million)
Figure 61 Key country dynamics
Figure 62 Australia AI in diagnostics market, 2021-2033 (USD Million)
Figure 63 Key country dynamics
Figure 64 South Korea AI in diagnostics market, 2021-2033 (USD Million)
Figure 65 Key country dynamics
Figure 66 Thailand AI in diagnostics market, 2021-2033 (USD Million)
Figure 67 Key country dynamics
Figure 68 Latin America AI in diagnostics market, 2021-2033 (USD Million)
Figure 69 Brazil AI in diagnostics market, 2021-2033 (USD Million)
Figure 70 Key country dynamics
Figure 71 Argentina AI in diagnostics market, 2021-2033 (USD Million)
Figure 72 Key country dynamics
Figure 73 Middle East and Africa AI in diagnostics market, 2021-2033 (USD Million)
Figure 74 South Africa AI in diagnostics market, 2021-2033 (USD Million)
Figure 75 Key country dynamics
Figure 76 Saudi Arabia AI in diagnostics market, 2021-2033 (USD Million)
Figure 77 Key country dynamics
Figure 78 UAE AI in diagnostics market, 2021-2033 (USD Million)
Figure 79 Key country dynamics
Figure 80 Kuwait AI in diagnostics market, 2021-2033 (USD Million)
Figure 81 Key country dynamics
Figure 82 Company categorization
Figure 83 Strategy mapping
Figure 84 Company market position analysis

Companies Mentioned

The leading players profiled in this Artificial Intelligence in Diagnostics market report include:
  • Siemens Healthineers
  • Zebra Technologies Corp.
  • Riverain Technologies
  • Vuno, Inc.
  • Aidoc
  • NovaSignal Corporation (previously known as Neural Analytics, acquired by NeuraSignal, Inc.)
  • Koninklijke Philips N.V.
  • Digital Diagnostics, Inc.
  • GE Healthcare
  • AliveCor Inc.
  • F. Hoffmann-La Roche Ltd

Table Information

Report AttributeDetails
No. of Pages150
PublishedJanuary 2026
Forecast Period2025 - 2033
Estimated Market Value ( USD ) in 2025 $ 1.97 Billion
Forecasted Market Value ( USD ) by 2033 $ 9.68 Billion
Compound Annual Growth Rate21.7%
Regions CoveredGlobal
No. of Companies Mentioned12

Related Topics

Related Reports

Artificial Intelligence in the Diagnostic Market Report 2026 - Product Image

Artificial Intelligence in the Diagnostic Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Computational Pathology Market Size, Share & Trends Analysis Report by Component (Software, Services), Application (Disease Diagnosis, Drug Discovery & Development, Academic Research), Technology, End-use, and Region with Growth Forecasts, 2026-2033 - Product Image

Computational Pathology Market Size, Share & Trends Analysis Report by Component (Software, Services), Application (Disease Diagnosis, Drug Discovery & Development, Academic Research), Technology, End-use, and Region with Growth Forecasts, 2026-2033

  • Report
  • 100 Pages
  • Global
From
Artificial Intelligence in Medical Diagnostics Market Report and Forecast 2025-2034 - Product Image

Artificial Intelligence in Medical Diagnostics Market Report and Forecast 2025-2034

  • Report
  • 400 Pages
  • Global
From
Artificial Intelligence in Medical Diagnostics Market - Global Forecast 2026-2032 - Product Image

Artificial Intelligence in Medical Diagnostics Market - Global Forecast 2026-2032

  • Report
  • 196 Pages
  • Global
From
Artificial Intelligence (AI) in Medical Diagnostics - Market Insights, Competitive Landscape, and Market Forecast - 2032 - Product Image

Artificial Intelligence (AI) in Medical Diagnostics - Market Insights, Competitive Landscape, and Market Forecast - 2032

  • Report
  • 150 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.